Nesiritide for the treatment of decompensated heart failure

This publication has 25 references indexed in Scilit:

• Safety and Effectiveness of Dofetilide for Conversion of Atrial Fibrillation and Nesiritide for Acute Decompensation of Heart Failure
  Circulation, 2000
• Natriuretic peptides in the pathophysiology of congestive heart failure
  Current Cardiology Reports, 2000
• The Natriuretic Peptides in Heart Failure: Diagnostic and Therapeutic Potentials
  Proceedings of the Association of American Physicians, 1999
• Cost-effectiveness Analysis in Clinical Practice
  Archives of internal medicine (1960), 1999
• Effect of Atrial Natriuretic Peptide on Muscle Sympathetic Activity and Its Reflex Control in Human Heart Failure
  Circulation, 1999
• Molecular and Cellular Mechanisms of Myocardial Failure
  The American Journal of Cardiology, 1997
• Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene.
  Circulation Research, 1992
• Atrial natriuretic factor: Its (patho)physiological significance in humans
  Kidney International, 1992
• Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide
  Endocrinology, 1992
• Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells.
  Journal of Clinical Investigation, 1991